Delivery Order 36C25524D0411-36C25526N0245
- Not listed
- The Department of Veterans Affairs, Veterans Integrated Service Network 17, issued a delivery order to Sofie CO. (doing business as IBA Molecular) on September 1, 2024, for $854,076.60 under a firm fixed-price arrangement for PYLARIFY F-18 isotopes, with an ultimate completion date of September 30, 2025. Place of performance is Sterling, VA. PYLARIFY (piflufolastat F-18) is a positron emission tomography imaging agent used for prostate cancer detection. No set-aside was applied to this...
- Sofie CO., doing business as IBA Molecular, was awarded a $241,784.24 firm fixed-price purchase order by the Department of Veterans Affairs' Veterans Integrated Service Network 5 on August 1, 2023, for delivery of PYLARIFY (piflufolastat F-18), a radioactive pharmaceutical used in positron emission tomography imaging for prostate cancer detection. The contract is designated as a total small business set-aside and specifies performance in Sterling, Virginia, with an ultimate completion date of...
- Sofie CO., doing business as IBA Molecular, was awarded a $992,398 delivery order by Veterans Integrated Service Network (VISN) 15, a component of the Department of Veterans Affairs, on June 1, 2024. The award is designated as a total small business set-aside and calls for the supply of PYLARIFY (piflufolastat F-18), a positron emission tomography (PET) imaging agent used for prostate cancer detection. Performance will be completed at the VA Saint Louis Health Care System in St. Louis, Missouri,...
- The U.S. Department of Veterans Affairs (VA) awarded a $1,104,268.32 firm-fixed-price purchase order contract to Sofie CO., doing business as IBA Molecular, for the purchase and delivery of 450 doses of the radiopharmaceutical PYLARIFY. This contract, set aside for total small business, supports the VA's medical imaging and cancer treatment programs at its Washington, D.C. medical center. Sofie CO. is a subsidiary of Sofie Biosciences, Inc., a specialized manufacturer and supplier of molecular...
- This delivery order represents a modification (MOD 36C24225N0240) to the PYLARIFY Ordering Period 3 contract, issued by the Veterans Integrated Service Network 2 (VISN 2) on January 1, 2025. The modification decreases unused Fiscal Year 2025 funds totaling $2.12 million under fund code 632C50062. Sofie CO., doing business as IBA Molecular, serves as the prime contractor and will continue supplying piflufolastat F-18 (PYLARIFY), a positron emission tomography imaging agent used for prostate...
- This contract, awarded by the Defense Health Agency (DHA), is for the delivery of PYLARIFY F 18 INJECTION, a radiopharmaceutical product used for positron emission tomography (PET) scanning of the prostate. The contract, with a ceiling value of $245,696.10, was awarded to Sofie CO., doing business as IBA Molecular, a for-profit subsidiary of Sofie Biosciences, Inc. This is a Blanket Purchase Agreement (BPA) call order, with a firm fixed-price pricing type. The contract has a period of...
- This federal contract award is for the provision of PYLARIFY radiopharmaceuticals and related services to the Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 (VISN 2). The prime contractor is Sofie CO., a subsidiary of Sofie Biosciences, Inc. that specializes in the development and delivery of molecular diagnostics and therapeutics. The $1,681,341.42 firm-fixed-price delivery order contract supports the VA's medical imaging and cancer treatment programs, enabling the...
- The Department of Veterans Affairs (VA) awarded a $1,198,895.04 firm fixed-price purchase order contract to Sofie CO., a small business prime contractor, for the purchase and delivery of the radiopharmaceutical PYLARIFY (Piflufolastat F-18 Injection) over a one-year period. This contract supports the VA's Veterans Health Administration and Veterans Integrated Service Network 5 for radiology services at the DC VA Medical Center. Sofie CO., a subsidiary of Sofie Biosciences, Inc., is an...
- This delivery order, awarded September 1, 2024, represents Option Year 2 of an existing contract vehicle with Sofie CO. (doing business as IBA Molecular), a Sterling, Virginia-based supplier of molecular diagnostics and therapeutic radiopharmaceuticals. The $194,870.88 firm fixed-price delivery order is funded by the Department of Veterans Affairs through Veterans Integrated Service Network 15 and is scheduled for completion by August 31, 2027. This award carries no set-aside designation and...
- This federal contract award, with an ID of 36C25521P0656, was made by the Veterans Integrated Service Network 15 (VISN 15) of the U.S. Department of Veterans Affairs (VA) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The contract is for the supply of PYLARIFY (piflufolastat F-18) injection, a radiopharmaceutical used for positron emission tomography (PET) imaging of prostate cancer. The contract has a ceiling value of $97,888.00 and is a firm-fixed-price purchase order, with an...
- 36C25524D0411Indefinite Delivery Contract
- 36C25524D0411-36C25526N0245Delivery Order
The Department of Veterans Affairs, Veterans Integrated Service Network 15, awarded a delivery order to Sofie CO. (doing business as IBA Molecular) on June 1, 2026, with a ceiling value of $1,172,834 for PYLARIFY F-18 DCFPYL radiopharmaceutical supply. The order is issued under a total small business set-aside and carries a firm fixed price. Place of performance is St. Louis, MO. The order's ultimate completion date is May 31, 2027. PYLARIFY (piflufolastat F-18) is a positron emission tomography imaging agent used for prostate cancer detection. Sofie CO. is a small business specializing in molecular diagnostics and therapeutic radiopharmaceuticals for federal healthcare applications, with an established portfolio of federal contracts serving the VA and Defense Health Agency across multiple medical treatment facilities nationwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2m | 5/4/26 |